CSIMarket
 
Dyax Corp  (DYAX)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 
Price: $0.0000 $0.00 %
Day's High: 0.00 Week Perf:
Day's Low: $ 0.00 30 Day Perf:
Volume (M): 0 52 Wk High: $ 0.00
Volume (M$): $ 0 52 Wk Avg: $0.00
Open: $0.00 52 Wk Low: $0.00



 Market Capitalization (Millions $) -
 Shares Outstanding (Millions) 147
 Employees -
 Revenues (TTM) (Millions $) 98
 Net Income (TTM) (Millions $) -30
 Cash Flow (TTM) (Millions $) 84
 Capital Exp. (TTM) (Millions $) 1

Business Description


Dyax Corp is a biopharmaceutical company that specializes in the development and commercialization of plasma kallikrein inhibitors. The company focuses on finding innovative ways to target and treat diseases associated with hereditary angioedema (HAE) and other plasma kallikrein-mediated disorders. Dyax Corp has developed a successful drug called Kalbitor, which is used to treat acute attacks of HAE in patients. In addition to its product development, Dyax Corp also invests in research and clinical trials to expand its pipeline and improve patient outcomes. The company was acquired by Shire plc in 2016, which further expanded its global reach and resources.




   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   





Fundamental Analysis

Valuation Current
Price to Earnings PE Ratio (TTM) -
Price to Earnings PE Ratio (Expected) -
Price to Sales (TTM) -
Price to Sales (Expected) -
Price to Book -
PEG (TTM) -

Financial Strength Current
Quick Ratio 10.8
Working Capital Ratio 11.66
Leverage Ratio (MRQ) 0.11
Total Debt to Equity -
Interest Coverage (TTM) -
Debt Coverage (TTM) -

Per Share Current
Earnings (TTM) -0.21 $
Revenues (TTM) 0.66 $
Cash Flow (TTM) 0.57 $
Cash 2.1 $
Book Value 2.14 $
Dividend (TTM) 0 $

Efficiency Current
Revenue per Employee (TTM) -
Net Income per Employee (TTM) -
Receivable Turnover Ratio (TTM) 8.49
Inventory Turnover Ratio (TTM) 3.27
Asset Turnover Ratio (TTM) 0.32

Profitability Ratios Current
Gross Margin (MRQ) 85.59 %
Operating Margin (MRQ) -34.34 %
Net Margin (MRQ) -47.32 %
Net Cash Flow Margin (MRQ) -42.66 %
Effective Tax Rate (TTM) -

Management Effectiveness Current
Return On Assets (TTM) -
Return On Investment (TTM) -
Return On Equity (TTM) -
Dividend Yield -
Pay out Ratio (TTM) -






Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.